Relapsed multiple myeloma
“At home the waiting list was longer than my doctors thought I had. In China the team answered every email and treatment started soon after I landed.”
After several lines of therapy, the cancer came back and no further options were available locally. CAR-T was approved abroad but had long waits.
The family exchanged dozens of messages with a hospital international team: a remote multidisciplinary review, a plain-language plan with risks, and help with the medical visa.
On arrival the team handled the SIM card, accommodation near the hospital and money transfer. Cells were collected, infused, and the patient was monitored as an inpatient before going home with a follow-up schedule.
These are not Kindvoya patients. Names and details are changed or combined; results vary and are not a promise of outcome.
Pattern drawn from public reports: www.globaltimes.cnenglish.shanghai.gov.cn